Status:
UNKNOWN
Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea
Lead Sponsor:
Asan Medical Center
Conditions:
Schizophrenia
Metabolic Syndrome
Eligibility:
All Genders
18-65 years
Brief Summary
The aim of this study is to examine the prevalence of the Metabolic syndrome(MetS) in Korean patients with schizophrenia. Primary objective: • To investigate the prevalence of the MetS in Korean pat...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of schizophrenia according to DSM-IV-TR
- Age between 18-65 years
Exclusion
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01477918
Start Date
December 1 2011
Last Update
November 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan medical center
Seoul, South Korea, 138-736